Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 2.83B | 12.4x | 2.32 | SGD 12.78 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 2.14B | 25.5x | -4.01 | SGD 2.79 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 88.03M | 8.6x | 0.5 | SGD 0.28 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 18.55M | -1.8x | -0.33 | SGD 0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 18.39M | 11.4x | 0.04 | SGD 0.58 | 11.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 5.21M | 3.3x | 0 | SGD 0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |